Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Daniel Batlle and Jan Wysocki.
Daniel Batlle
Connection Strength
2.768
Jan Wysocki
  1. A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids. J Am Soc Nephrol. 2021 Feb 01.
    View in: PubMed
    Score: 0.927
  2. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19. J Am Soc Nephrol. 2020 09; 31(9):1941-1943.
    View in: PubMed
    Score: 0.892
  3. ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery. Clin Sci (Lond). 2020 11 13; 134(21):2791-2805.
    View in: PubMed
    Score: 0.228
  4. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications. Hypertension. 2020 11; 76(5):1339-1349.
    View in: PubMed
    Score: 0.225
  5. An update on ACE2 amplification and its therapeutic potential. Acta Physiol (Oxf). 2021 01; 231(1):e13513.
    View in: PubMed
    Score: 0.222
  6. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci (Lond). 2020 03 13; 134(5):543-545.
    View in: PubMed
    Score: 0.218
  7. The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation. FASEB J. 2020 08; 34(8):10505-10515.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.